Viewing Study NCT02866227

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:06 AM
Ignite Modification Date: 2026-04-12 @ 4:27 AM
Study NCT ID: NCT02866227
Status: COMPLETED
Last Update Posted: 2018-03-09
First Post: 2016-07-28
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: TOL-463 Phase 2 Study for Vaginitis
Sponsor: Toltec Pharmaceuticals, LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bacterial Vaginosis View
None Vulvovaginal Candidiasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bacterial View
None Candidiasis View
None Gel View
None Insert View
None TOL-463 View
None Vaginal View
None Vaginitis View
None Vaginoses View
None Vulvovaginal View